Placental, maternal serum and amniotic fluid molecular weight forms of inhibin A and pro-αC

Placenta

Volumn 24, Issue 4, 2003, Pages 370-377

  Thirunavukarasu, P ^a   Robertson, D M ^b   Dole, A ^a   Waldron, K ^c   Dawson, G ^c   Wallace, Euan M ^a,c  

^a MONASH UNIVERSITY   (Australia)

^b HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c MONASH MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INHIBIN A; INHIBIN B;

ALPHA CHAIN; AMNION FLUID; ARTICLE; CHI SQUARE TEST; CONTROLLED STUDY; ELUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN TISSUE; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOREACTIVITY; MATERNAL BLOOD; MATERNAL SERUM; MOLECULAR SIZE; MOLECULAR WEIGHT; PLACENTA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PREGNANCY; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY;

EID: 0141614988     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1053/plac.2002.0921     Document Type: Article

References (44)

1. Aitken DA, Wallace EM, Crossley JA, Swanston IA, van Parenen Y, van Maarle M, Groome NP, Macri JN & Connor JM (1996) Dimeric inhibin-A as a marker for Down's syndrome in early pregnancy. N Eng J Med, 334, 1321-1326.
2. Byun D, Mohan S, Kim C, Suh K, Yoo M, Lee H, Baylink D & Qin X (2000) Studies on human pregnancy-induced insulin-like growth factor (IGF)-binding protein-4 proteases in serum: determination of IGF-II dependency and localization of cleavage site. J Clin Endocrinol Metab, 85, 373-381.
3. De Kretser DM, Foulds LM, Hancock M & Robertson DM (1994) Partial characterization of inhibin, activin and follistatin in the term human placenta. J Clin Endocrinol Metab, 79, 502-507.
4. Florio P, Benedetto C, Luisi S, Santuz M, Di Carlo C, Marozio L, Genazzani AR & Petraglia F (1999) Activin A, inhibin A, inhibin B and parturition: changes of maternal and cord serum levels according to the mode of delivery. Brit J Obstet Gynaecol, 106, 1061-1065.
5. Fowler PA, Evans LW, Groome NP, Templeton A & Knight PG (1998) A longitudinal study of maternal serum inhibin-A, inhibin-B, activin-A, activin-AB, pro-alpha C and follistatin during pregnancy. Hum Reprod, 13, 3530-3536.
6. Groome NP & O'Brien M (1993) Two-site immunoassays for inhibin and its subunits. Further applications of the synthetic peptide approach. J Immunol Methods, 165, 167-176.
7. Groome NP, Illingworth PJ, O'Brien M, Piddle J, Weaver K & McNeilly AS (1995) Quantitation of inhibin pro-αC containing forms in human serum by a new ultrasensitive two-site enzyme-linked immunosorbent assay. J Clin Endocrinol Metab, 80, 2926-2932.
8. Groome NP, Illingworth PJ, O'Brien M, Pai R, Mather J, Rodger FE & McNeilly AS (1996) Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab, 81, 1401-1405.
9. Illingworth PJ, Groome NP, Duncan WC, Grant V, Tovanabutra S, Baird DT & McNeilly AS (1996) Measurement of circulating inhibin forms during the establishment of pregnancy. J Clin Endocrinol Metab, 81, 1471-1475.
10. Irwin JC, Suen LF, Cheng BH, Martin R, Cannon P, Deal CL & Giudice LC (2000) Human placental trophoblasts secrete a disintegrin metalloproteinase very similar to the insulin-like growth factor binding protein-3 protease in human pregnancy serum. Endocrinology, 141, 666-674.
11. Kardana A & Cole LA (1994) Human chorionic gonadotropin β-subunit nicking enzymes in pregnancy and cancer patient serum. J Clin Endocrinol Metab, 79, 761-767.
12. Keelan J, Song Y & France JT (1994) Comparative regulation of inhibin, activin and human chorionic gonadotrophin production by placental trophoblast cells in culture. Placenta, 15, 803-818.
13. Khalil A, Kaufmann RC, Wortsman J, Winters SJ & Huffman DG (1995) Inhibin in normal and abnormal pregnancy: maternal serum concentration and partial characterization. Am J Obstet Gynaecol, 172, 1019-1025.
14. McLachlan RI, Robertson DM, Burger HG & de Kretser DM (1986)The radioimmunoassay of bovine and human follicular fluid and serum inhibin. Mol Cell Endocrinol, 55, 882-887.
15. Miyamoto K, Hasegawa Y, Fukuda M & Igarashi M (1986) Demonstration of high molecular weight forms of inhibin in bovine follicular fluid (bFF) by using monoclonal antibodies to bFF 32k inhibin. Biochem Biophys Res Commun, 136, 1103-1109.
16. Muttukrishna S, George L, Fowler PA, Groome NP & Knight PG (1995) Measurement of serum concentrations of inhibin A (a-bA) dimer during human pregnancy. Clin Endocrinol, 42, 391-397.
17. Muttukrishna S, Child TJ, Groome NP & Ledger WL (1997a) Source of circulating levels of inhibin A, pro alpha C-containing inhibins and activin A in early pregnancy. Hum Reprod, 12, 1089-1093.
18. Muttukrishna S, Knight PG, Groome NP, Redman CWG & Ledger WL (1997b) Activin A and inhibin A as possible endocrine markers for preeclampsia. Lancet, 349, 1285-1288.
19. Nakayama K (1997) Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins. J Biochem, 327, 625-635.
20. Petraglia F, Anceschi MM, Calza L, Garutti GC, Fusaro P, Giardino L, Genazzani AR & Vale W (1993) Inhibin and activin in human fetal membranes: evidence for a local effect on prostaglandin release. J Clin Endocrinol Metab, 77, 542-548.
21. Petraglia F, Luisi S, Benedetto C, Zonca M, Florio P, Casarosa E, Volpe A, Bernasconi S & Genazzani AR (1997) Changes in dimeric inhibin B levels in maternal serum throughout healthy gestation and in women with gestational diseases. J Clin Endocrinol Metab, 82, 2991-2995.
22. Qu J & Thomas K (1992) Changes in bioactive and immunoactive inhibin levels around human labour. J Clin Endocrinol Metab, 74, 1290-1295.
23. Rabinovici J, Goldsmith PC, Librach CL & Jaffe RB (1991) Localisation and secretion of inhibin/activin subunits in the human and subhuman primate fetal gonads. J Clin Endocrinol Metab, 73, 1141-1149.
24. Riley SC, Wathen N, Chard T, Groome NP, Wallace EM (1996) Inhibins in extra-embryonic coelomic and amniotic fluids and maternal serum in early pregnancy. Human Reproduction, 11, 2722-2776.
25. Riley SC, Leask R, Balfour C, Brennand JE & Groome NP (2000) Production of inhibin forms by the fetal membranes, deciduas, placenta and fetus at parturition. Hum Reprod, 15, 578-583.
26. Robertson DM, Foulds LM, Leversha L, Morgan FJ, Hearn MTW, Burger HG, Wettenhall REH & de Kretser DM (1985) Isolation of inhibin from bovine follicular fluid. Biochem Biophys Res Commun, 126, 220-226.
27. Robertson DM, de Vos F, McLachlan RI, Salamonsen LA, Hearn MTW, Morgan FJ, Findlay JK, Burger HG & de Kretser DM (1987) Purification of inhibin and its isoforms. Serono Symposium, 42, 17-34.
28. Robertson DM, Sullivan J, Watson M & Cahir N (1995) Inhibin forms in human plasma. J Endocrinol, 14, 261-269.
29. Robertson DM, Burger HG, Sullivan J, Cahir N, Groome N, Poncelet E, Franchimont P, Woodruff T & Mather JP (1996) Biological and immunological characterization of inhibin forms in human plasma. J Clin Endocrinol Metab, 81, 669-676.
30. Robertson DM, Cahir N, Findlay JK, Burger HG & Groome N (1997) The biological and immunological characterisation of inhibin A and B forms in human follicular fluid and plasma. J Clin Endocrinol Metab, 82, 889-896.
31. Simmons D, France JT, Keelan JA, Song L & Knox BS (1994) Sex differences in umbilical cord serum levels of inhibin, testosterone, oestradiol, dehydroepiandrosterone sulphate, and sex hormone-binding globulin in human term neonates. Biol Neonate, 65, 287-294.
32. Sugino K, Nakamura T, Takio K, Miyamoto K, Hasegawa Y, Igarashi M, Titani K & Sugino H (1992) Purification and characterization of high molecular weight forms of inhibin from bovine follicular fluid. Endocrinol, 130, 789-796.
33. Thirunavukarasu P, Stephenson T, Forray J, Stanton PG, Groome N, Wallace E & Robertson DM (2001) Changes in molecular weight forms of inhibin A and pro-aC in maternal serum during human pregnancy. J Clin Endocrinol Metab, 86, 5794-5804.
34. Thirunavukarasu PP, Lambert-Messerlian G, Robertson DR, Dawson G, Canick J & Wallace EM (2002) Molecular weight forms of inhibin A, inhibin B and pro-aC in maternal serum, amniotic fluid and placental extracts of normal and Down syndrome pregnancies. Prenat Diag, 12, 478-482.
35. Tierney ML, Goss NH & Tomkins SM (1990) Physicochemical and biological characterisation of recombinant human inhibin A. Endocrinol, 126, 3268-3270.
36. Tong S, Wallace EM & Burger HG (in press) Inhibins and activins: clinical advances in reproductive medicine. Clin Endocrinol (Oxf).
37. Vale WW, Hseuh A, Rivier C & Yu J (1990) The inhibin/activin family of hormones and growth factors. In Peptide Growth Factors and their Receptors: Handbook of Experimental Physiology. Volume 95 (Eds) Sporn MA & Roberts AB, pp. 211-248. Berlin: Springer-Verlag.
38. Wallace EM & Healy DL (1996) Inhibins and activins: roles in clinical practice. Brit J Obstet Gynaecol, 103, 945-956.
39. Wallace EM, Riley SC, Crossley JA, Ritoe SC, Horne A, Shade M, Ellis PM, Aitken DA & Groome NP (1997a) Dimeric inhibins in amniotic fluid, maternal serum, and fetal serum in human pregnancy. J Clin Endocrinol Metab, 82, 218-222.
40. Wallace EM, Crossley JA, Groome NP & Aitken DA (1997b) Inhibin-A in amniotic fluid in chromosomally normal and Down's syndrome pregnancies. J Endocrinol, 152, 109-112.
41. Wallace EM (1999) Inhibins, activins and follistatin in amniotic fluid in normal and Down syndrome pregnancy. In Amniotic Fluid (Ed.) Rao KA, pp. 41-51. Bangalore, India: Prism Books.
42. Wallace EM, Schneider-Kolsky ME & Thirunavukarasu P (2000) Activin A, inhibin A, inhibin B and parturition: changes of maternal and cord serum levels according to the mode of delivery. Brit J Obstet Gynaecol, 107, 704.
43. Yair D, Eshed-Englender T, Kupferminc MJ, Geva E, Frenkel J & Sherman D (2001) Serum levels of inhibin B, unlike inhibin A and activin A, are not altered in women with preeclampsia. Am J Rep Immunol, 4, 180-187.
44. Ying SY (1988) Inhibins, activins and follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone. Endocr Rev, 9, 267-293.